Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Bullboard Posts
Comment by Fundy13on Nov 21, 2018 2:31pm
122 Views
Post# 29006098

RE:RE:RE:RE:RE:RE:RE:RE:From Analyist

RE:RE:RE:RE:RE:RE:RE:RE:From AnalyistHUGE has been very good at creating shares, so I really do not think it will be an issue, just trying to think of petential reason for the release not being out yet.
It would be easy to have it at a set price, they just agree to issue a set number of shares rather then a set $ amount.  They could use the $48million and base it on the 20 day moving average fromt eh past 20 days, which would be $0.45 mean each TRPX share would be converted into 35.5  shares of HUGE.  it would be changing the LOI terms but if both parties agree then it can be done.
Right now all of the risk of SP changes falls on HUGE which is great for TRPX share holders.
This is all complete speculation like I said.
Bullboard Posts